Home › Funds › ATWOOD & PALMER INC › GILD
ATWOOD & PALMER INC position in GILD
GILEAD SCIENCES INC · Health Care
ATWOOD & PALMER INC reported holding 351,309 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$52.4M, representing 2.69% of its reported portfolio and ranking #10 among its reported holdings. ATWOOD & PALMER INC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR
How ATWOOD & PALMER INC's GILD position evolved
ATWOOD & PALMER INC first disclosed a stake in GILD in Q3 2023 at 337,944 shares (US$25.3M). The position peaked in Q3 2026 at 351,309 shares, worth US$52.4M. Across 13 filings, ATWOOD & PALMER INC increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 351,309 shares valued at US$52.4M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 337.94K | $25.33M | New |
| Q4 2023 | 338.42K | $27.42M | Hold |
| Q1 2024 | 346.79K | $25.40M | Add |
| Q2 2024 | 345.94K | $23.74M | Hold |
| Q3 2024 | 346.68K | $29.07M | Hold |
| Q4 2024 | 349.26K | $32.26M | Add |
| Q1 2025 | 345.07K | $38.66M | Reduce |
| Q2 2025 | 344.08K | $38.15M | Hold |
| Q3 2025 | 344.15K | $38.20M | Hold |
| Q4 2025 | 349.83K | $42.94M | Add |
| Q1 2026 | 347.44K | $48.42M | Reduce |
| Q2 2026 | 350.24K | $44.25M | Add |
| Q3 2026 | 351.31K | $52.36M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GILD and 13F data
GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GILD
- Fidelity Management & Research (FMR) 66.87M sh · $8.45B · Q2 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- Invesco Ltd 39.82M sh · $5.03B · Q2 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 30.00M sh · $3.79B · Q2 2026
- Dodge & Cox 23.68M sh · $2.99B · Q2 2026
- DODGE & COX 23.68M sh · $2.99B · Q2 2026
More on ATWOOD & PALMER INC
FAQ
How long has ATWOOD & PALMER INC held GILD?
ATWOOD & PALMER INC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is ATWOOD & PALMER INC's current position in GILD?
As of Q3 2026, ATWOOD & PALMER INC holds 351.31K shares of GILD (GILEAD SCIENCES INC), valued at $52.36M, representing 2.69% of its reported portfolio and ranking #10.
Has ATWOOD & PALMER INC been buying or selling GILD?
In the latest 13F filing (Q3 2026), ATWOOD & PALMER INC held unchanged its position in GILD. The position peaked in Q3 2026 at 351.31K shares.
Which other funds hold GILD?
Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.